logo

For the Inventor, By the Inventor

Granger, IN, United States of America

Julian R Pleasants

This inventor holds 9 USPTO granted patents, plus 2 CIPO patents. Top assignee: American Biogenetic Sciences, Inc.. Active years: 1992-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julian R Pleasants. Retrieved from https://idiyas.com/inventor/julian-r-pleasants

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 78(Granted Patents)


Company Filing History:

goldMedal9 out of 23 
 
American Biogenetic Sciences, Inc.
 patents

Years Active: 1992-2001

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 6294173 - Methods for treating a tumor containing fibrin using a fibrin specific monoclonal antibody and compositions used therein (2001-09-25),
2. 6187593 - Methods for treating a fibrin encapsulated tumor using a fibrin specific monoclonal antibody and compositions used therein (2001-02-13),
3. 5871737 - Methods for treating a fibrin encapsulated tumor using a fibrin specific (1999-02-16),
4. 5723126 - Methods and compositions for therapeutic uses of a fibrin-specific (1998-03-03),
5. 5721122 - Method comprising immunization of antigen-free mice (1998-02-24),
6. 5453359 - Immunoassay and kit for in vitro detection of soluble DesAABB fibrin (1995-09-26),
7. 5223410 - Method for production of antibodies utilizing an antigen-free animal (1993-06-29),
8. 5120834 - Fibrin-specific monoclonal antibody (1992-06-09),
9. 5091512 - Fibrinogen-specific monoclonal antibody (1992-02-25),

Title: Innovations of Julian R Pleasants

Introduction

Julian R Pleasants is a notable inventor based in Granger, Indiana, who has made significant contributions to the field of biomedical sciences. With a total of nine patents to his name, he has focused on developing innovative methods for treating tumors and producing monoclonal antibodies.

Latest Patents

Among his latest patents are methods for treating a tumor containing fibrin using a fibrin-specific monoclonal antibody and compositions used therein. This invention relates to a method for the production of monoclonal antibodies utilizing an immunized germ-free animal. The invention also provides methods for the use of such monoclonal antibodies, as well as polyclonal antibodies derived from an immunized germ-free animal, for both in vitro and in vivo clinical diagnostics and therapeutics. Additionally, he has developed methods for treating a fibrin-encapsulated tumor using a fibrin-specific monoclonal antibody and compositions used therein, further emphasizing his commitment to advancing medical treatments.

Career Highlights

Julian R Pleasants is currently associated with American Biogenetic Sciences, Inc., where he continues to innovate and contribute to the field. His work has been instrumental in the development of new therapeutic methods that have the potential to improve patient outcomes.

Collaborations

He has collaborated with notable colleagues such as Paul E Gargan and Victoria A Ploplis, enhancing the scope and impact of his research through teamwork and shared expertise.

Conclusion

Julian R Pleasants exemplifies the spirit of innovation in the biomedical field, with his patents reflecting a dedication to improving clinical diagnostics and therapeutics. His contributions are paving the way for advancements in cancer treatment and antibody production.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…